Bayer, Novartis Settle MS Drug Dispute For $200M
Betaseron, also known as Interferon beta-1b, is used to treat relapsing forms of multiple sclerosis. It is a big moneymaker for Bayer, drawing €1 billion ($1.3 million) in sales in 2006.
Under the agreement, Bayer will pay around $200 million for the transfer of production...
To view the full article, register now.